UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000022986
Receipt number R000026455
Scientific Title Quantitative analysis of hippotherapy in patients with walking disabilities
Date of disclosure of the study information 2016/07/02
Last modified on 2019/07/01 20:15:57

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Quantitative analysis of hippotherapy in patients with walking disabilities

Acronym

Evaluation of hippotherapy using quantitative indicators

Scientific Title

Quantitative analysis of hippotherapy in patients with walking disabilities

Scientific Title:Acronym

Evaluation of hippotherapy using quantitative indicators

Region

Japan


Condition

Condition

Patients presented with walking disabilities due to cerebral palsy, hydrocephalus (post-treatment), and stroke.

Classification by specialty

Pediatrics Rehabilitation medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Hippotherapy is a treatment strategy that usesequine movement as part of an integrated intervention program for achieving functional outcomes. The aim of this study was to evaluate the effects of hippotherapy on temporospatial parameters of gait and balance abilities in patients with walking disabilities.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Short- and long-term improvement of hippothray assessed by Gross Motor Function Measure (GMFM).Temporospatial parameters of gait and balance abilities using a tri-axial motion recorder analysis for a 5-m or 10-m walikng test, score for dimensions D (standing) and E (walking, running, jumping) of the GMFM. Comparison was performed with control (recreation) or age-matched normal database subjects.

Key secondary outcomes

WHOQOL-BREF (Japanese version), CPQOL-child/-caregiver.


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -but assessor(s) are blinded

Control

Active

Stratification

YES

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

No need to know


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

Hippotherapy (30min once weekly)

Interventions/Control_2

Control group without hippotherapy (e.g., recreation, non-therapeutic intervention) or age-matched normal database.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

4 years-old <=

Age-upper limit

80 years-old >=

Gender

Male and Female

Key inclusion criteria

Children and adolescents with cerebral palsy in the Kanto region of Japan were recruited by contacting the schools that cater for them with appropriate physiotherapy services, as well as via adjacent hospital/clinics.

Key exclusion criteria

Exclusion criteria included if they had 1) previous participation in hippotherapy, 2) history of fracture or epilepsy within 8 weeks of enrolment, and 3) cognitive or physical impairment sufficiently severe that would hinder study protocol. In addition, participants were excluded if they received medication or orthopedic surgery (e.g., botulinum toxin injection and selective dorsal rhizotomy) for treating tight muscles and spasticity related to CP during the study or within 3 months of the enrollment.

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Hirokazu
Middle name
Last name Tsubone

Organization

Graduate School of Agricultural and Life Sciences, The University of Tokyo

Division name

Research Center for Food Safety

Zip code

113-8657

Address

1-1-1 Yayoi, Bunkyo-ku, Tokyo 113-8657, Japan

TEL

03-5841-5004

Email

tsuhiro123@yahoo.co.jp


Public contact

Name of contact person

1st name Tatsushi
Middle name
Last name Mutoh

Organization

Institute of Development, Aging and Cancer, Tohoku University

Division name

Department of Nuclear Medicine and Radiology

Zip code

980-8575

Address

4-1 Seiryo-machi, Aoba-ku, Sendai 980-8575, Japan

TEL

022-717-8559

Homepage URL


Email

tmutoh@tohoku.ac.jp


Sponsor or person

Institute

Holistic Betterment and Wellness Through Riding PIROUETTE, Japan

Institute

Department

Personal name



Funding Source

Organization

Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (18K10773)

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Holistic Betterment and Wellness Through Riding PIROUETTE

Address

277701 Hiraide-cho, Utsunomiya, Japan

Tel

022-717-8559

Email

tsuhiro123@yahoo.co.jp


Secondary IDs

Secondary IDs

YES

Study ID_1

SPTS2016007

Org. issuing International ID_1

The Society of Physical Therapy Science Ethics Committee

Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

障がい者のための馬事普及協会「ピルエット」


Other administrative information

Date of disclosure of the study information

2016 Year 07 Month 02 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

30

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2013 Year 01 Month 01 Day

Date of IRB

2016 Year 12 Month 22 Day

Anticipated trial start date

2013 Year 04 Month 01 Day

Last follow-up date

2019 Year 06 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2016 Year 07 Month 02 Day

Last modified on

2019 Year 07 Month 01 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000026455


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name